Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics Sep 30, 2019 07:30AM
Histogenics (HSGX) to be Acquired by Ocugen Apr 8, 2019 07:07AM
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics Apr 8, 2019 07:00AM
Histogenics (HSGX) Says FDA Indicated Additional Trial Needed to Complete Submission of BLA for NeoCart Dec 21, 2018 04:07PM
Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway Dec 21, 2018 04:05PM


Oct 10, 2018 04:01PM Histogenics Corporation Announces Closing of Public Offering of Common Stock and Warrants
Oct 5, 2018 08:11AM Histogenics (HSGX) Prices Public Offering of Common Stock, Warrants
Oct 5, 2018 08:10AM Histogenics Corporation Announces Pricing of Public Offering of Common Stock and Warrants
Oct 4, 2018 04:02PM Histogenics (HSGX) Announces Proposed Common Share Public Offering
Oct 4, 2018 04:01PM Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants
Sep 26, 2018 04:07PM Histogenics (HSGX) to Meet With FDA to Discuss NeoCart Phase 3 Clinical Trial Data, Potential Regulatory Pathway
Sep 26, 2018 04:05PM Histogenics to Meet With FDA to Discuss NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway
Jul 25, 2018 04:15PM Histogenics Corporation to Present at Canaccord Genuity’s 38th Annual Growth Conference
Feb 20, 2018 08:30AM Histogenics Corporation to Present at Upcoming Investor Conferences
Jan 25, 2018 04:05PM Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Jan 23, 2018 05:42AM Histogenics (HSGX) Prices 2.34M Common Shares at $2.35/Sh
Jan 22, 2018 06:59PM Histogenics Corporation Announces Pricing of Underwritten Registered Direct Offering of 2,340,430 Shares of Common Stock
Jul 26, 2017 08:30AM Histogenics Corporation to Present at the 37th Annual Canaccord Genuity Growth Conference
Feb 23, 2017 08:30AM Histogenics Corporation to Present at Upcoming Investor Conferences
Jul 27, 2016 08:30AM Histogenics Corporation to Present at the Canaccord Genuity Growth Conference
Feb 25, 2016 08:30AM Histogenics Corporation to Present at Upcoming Investor Conferences
Aug 4, 2015 08:30AM Histogenics Corporation to Present at the Canaccord Genuity Growth Conference
Aug 4, 2015 08:30AM Histogenics Corporation to Present at the Canaccord Genuity Growth Conference
Mar 17, 2015 08:30AM Histogenics Corporation to Present at the 2015 Canaccord Genuity Musculoskeletal Conference
Jan 5, 2015 08:00AM Canaccord Genuity Starts Histogenics Corp. (HSGX) at Buy
Dec 3, 2014 11:04AM Histogenics (HSGX) IPO Opens Higher after Weak Pricing
Dec 3, 2014 08:48AM Histogenics (HSGX) IPO Prices at $11, Below Expected Range
Dec 2, 2014 06:46PM Histogenics Corporation Announces Pricing of Initial Public Offering